Logo image of SLNH

SOLUNA HOLDINGS INC (SLNH) Stock Fundamental Analysis

USA - NASDAQ:SLNH - US5835433013 - Common Stock

2.57 USD
-0.26 (-9.19%)
Last: 10/9/2025, 9:41:01 PM
2.68 USD
+0.11 (+4.28%)
Pre-Market: 10/10/2025, 8:46:48 AM
Fundamental Rating

1

SLNH gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. Both the profitability and financial health of SLNH have multiple concerns. SLNH is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year SLNH has reported negative net income.
SLNH had a negative operating cash flow in the past year.
In the past 5 years SLNH reported 4 times negative net income.
In multiple years SLNH reported negative operating cash flow during the last 5 years.
SLNH Yearly Net Income VS EBIT VS OCF VS FCFSLNH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

1.2 Ratios

SLNH's Return On Assets of -67.58% is on the low side compared to the rest of the industry. SLNH is outperformed by 87.54% of its industry peers.
Industry RankSector Rank
ROA -67.58%
ROE N/A
ROIC N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SLNH Yearly ROA, ROE, ROICSLNH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

SLNH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SLNH Yearly Profit, Operating, Gross MarginsSLNH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200

More info and screens

0

2. Health

2.1 Basic Checks

SLNH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SLNH has been increased compared to 1 year ago.
Compared to 5 years ago, SLNH has more shares outstanding
The debt/assets ratio for SLNH is higher compared to a year ago.
SLNH Yearly Shares OutstandingSLNH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
SLNH Yearly Total Debt VS Total AssetsSLNH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -5.65, we must say that SLNH is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -5.65, SLNH is doing worse than 84.70% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.65
ROIC/WACCN/A
WACC10.97%
SLNH Yearly LT Debt VS Equity VS FCFSLNH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

SLNH has a Current Ratio of 0.35. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
SLNH has a Current ratio of 0.35. This is amonst the worse of the industry: SLNH underperforms 92.88% of its industry peers.
SLNH has a Quick Ratio of 0.35. This is a bad value and indicates that SLNH is not financially healthy enough and could expect problems in meeting its short term obligations.
SLNH's Quick ratio of 0.35 is on the low side compared to the rest of the industry. SLNH is outperformed by 92.17% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
SLNH Yearly Current Assets VS Current LiabilitesSLNH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.72% over the past year.
The Revenue for SLNH has decreased by -26.88% in the past year. This is quite bad
SLNH shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 42.07% yearly.
EPS 1Y (TTM)51.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.33%
Revenue 1Y (TTM)-26.88%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-36.35%

3.2 Future

SLNH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 33.85% yearly.
SLNH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.85% yearly.
EPS Next Y76.23%
EPS Next 2Y33.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-13.88%
Revenue Next 2Y10.85%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
SLNH Yearly Revenue VS EstimatesSLNH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
SLNH Yearly EPS VS EstimatesSLNH Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 -0.5 -1 -1.5 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SLNH. In the last year negative earnings were reported.
Also next year SLNH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SLNH Price Earnings VS Forward Price EarningsSLNH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SLNH Per share dataSLNH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

A more expensive valuation may be justified as SLNH's earnings are expected to grow with 33.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.85%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SLNH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SOLUNA HOLDINGS INC

NASDAQ:SLNH (10/9/2025, 9:41:01 PM)

Premarket: 2.68 +0.11 (+4.28%)

2.57

-0.26 (-9.19%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-14 2025-11-14
Inst Owners4.95%
Inst Owner Change0%
Ins Owners19.49%
Ins Owner Change58.35%
Market Cap96.61M
Analysts43.33
Price TargetN/A
Short Float %20.75%
Short Ratio0.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)23.95%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-8.55%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.46
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-6.19
EYN/A
EPS(NY)-2.1
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.74
BVpS-0.52
TBVpS-0.86
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -67.58%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-73.36%
ROA(5y)-40.37%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.33%
Cap/Sales 76.61%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z -5.65
F-Score1
WACC10.97%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)534.63%
Cap/Sales(3y)102.76%
Cap/Sales(5y)154.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)51.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%79.33%
EPS Next Y76.23%
EPS Next 2Y33.85%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.88%
Revenue growth 3Y38.37%
Revenue growth 5Y42.07%
Sales Q2Q%-36.35%
Revenue Next Year-13.88%
Revenue Next 2Y10.85%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-223.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y5.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y75.44%
OCF growth 3YN/A
OCF growth 5YN/A